MegazoneCloud Begins Building Hanmi Pharmaceutical's Quality Assurance AI Agent with 'AIR Studio'

Fine-tunes the Korean model Solar and deploys it on its own AI platform, AIR Studio, to automate quality-document operations

Part of the MSIT•NIPA 'AX One-Stop Voucher Program'; consortium formed with Hanmi Pharmaceutical, Samsung SDS, and Selectstar

SEOUL, South Korea, Sept. 9, 2026 /PRNewswire/ -- MegazoneCloud (CEO Doug Yeum), a leading AI and cloud company, is undertaking the development of 'Hanmi Q-Agent,' an AI agent that automates Hanmi Pharmaceutical's quality assurance (QA) operations, based on its enterprise AI OS 'AIR Studio.'

Hanmi Q-Agent is an AI agent that supports the retrieval and analysis of vast quality documents. MegazoneCloud, which is responsible for implementing the AI solution for this project — part of the 'AX One-Stop Voucher Program,' through which the Ministry of Science and ICT (MSIT) and the National IT Industry Promotion Agency (NIPA) provide integrated support for AI, cloud, and data in voucher form — began system development on the 7th.

MegazoneCloud will build the search-based AI agent for some 4,000 quality documents accumulated by Hanmi Pharmaceutical. Applying its in-house enterprise AI OS 'AIR Studio,' the company will implement a RAG (retrieval-augmented generation)-based agent that retrieves and summarizes these documents and compares them against the latest regulations. The goal is to identify and correct items that do not conform to newly added or revised regulations, thereby reducing related work time by more than 40%.

Quality documents are prepared and managed to demonstrate that pharmaceuticals have been manufactured consistently and in accordance with regulations; they contain a mix of tables, figures, and formulas, with Korean and English notation used side by side. Until now, staff have had to search through vast volumes of documents themselves and manually cross-check them against the latest regulatory standards and internal guidelines. In particular, discrepancies with regulations have mostly been corrected only after inspections. Once the system is in place, preventive quality management that reflects the latest regulations in real time is expected to become possible.

As the engine that generates Hanmi Q-Agent's responses, MegazoneCloud fine-tunes Upstage's Korean model 'Solar' to Hanmi Pharmaceutical's GMP domain and deploys it on the AIR Studio-based agent. GMP (Good Manufacturing Practice) is an international standard for manufacturing pharmaceuticals at a consistent level of quality and is central to pharmaceutical quality assurance operations.

Suh Min-taek, Vice President of MegazoneCloud, said, "The pharmaceutical quality field is one of the most demanding areas for AI adoption, as a single word can determine a regulatory judgment and the requirements for accuracy and traceability are exceptionally strict." He added, "Having proven our AIR Studio and fine-tuning capabilities through generative-AI implementations across a range of industries, such as Hanatour's AI chat consultation service, we will lead the expansion of domain-specific AI in regulated industries through this project."

In the Hanmi Q-Agent project, Hanmi Pharmaceutical serves as the overall lead, while MegazoneCloud handles AI solution implementation and fine-tuning, Samsung SDS provides the AX infrastructure, and Selectstar performs data processing and third-party verification. The four companies held the "2026 AX One-Stop Voucher Program Hanmi Pharmaceutical Consortium Kickoff" on August 28.

About MegazoneCloud

MegazoneCloud is a leading AI and cloud-native company with some 2,000 AI and cloud experts, serving as an enterprise AI orchestrator that supports the AI transformation (AX) and business innovation of more than 8,000 customers in Korea and abroad. Built on partnerships with major global and domestic CSPs and an ecosystem of over 200 ISV partners, together with its own cloud, AI, data, and security solutions, the company provides end-to-end services — from AI strategy and data development to infrastructure modernization and the development and operation of AI models and AI agents — enabling enterprises to operate complex AI environments effectively and create business results in the multi-agent era.

Under its vision "Transform Tomorrow, Together," MegazoneCloud is establishing itself as a strategic partner for customers' AI innovation and growth across 10 countries, including Korea, North America, Japan, Southeast Asia, Oceania, and the Middle East.

View original content:https://www.prnewswire.com/news-releases/megazonecloud-begins-building-hanmi-pharmaceuticals-quality-assurance-ai-agent-with-air-studio-302875865.html

SOURCE MegazoneCloud